Cargando…
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
BACKGROUND: Insulin glargine (Lantus®) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([Gly(A21)]ins...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832019/ https://www.ncbi.nlm.nih.gov/pubmed/20209060 http://dx.doi.org/10.1371/journal.pone.0009540 |
_version_ | 1782178313768271872 |
---|---|
author | Sommerfeld, Mark R. Müller, Günter Tschank, Georg Seipke, Gerhard Habermann, Paul Kurrle, Roland Tennagels, Norbert |
author_facet | Sommerfeld, Mark R. Müller, Günter Tschank, Georg Seipke, Gerhard Habermann, Paul Kurrle, Roland Tennagels, Norbert |
author_sort | Sommerfeld, Mark R. |
collection | PubMed |
description | BACKGROUND: Insulin glargine (Lantus®) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([Gly(A21)]insulin) and M2 ([Gly(A21),des-Thr(B30)]insulin). The aim of this study was to characterize the glargine metabolites in vitro with regard to their insulin receptor (IR) and IGF-1 receptor (IGF1R) binding and signaling properties as well as their metabolic and mitogenic activities. METHODS: The affinity of human insulin, insulin glargine and its metabolites to the IR isoforms A and B or IGF1R was analyzed in a competitive binding assay using SPA technology. Receptor autophosphorylation activities were studied via In-Cell Western in CHO and MEF cells overexpressing human IR-A and IR-B or IGF1R, respectively. The metabolic response of the insulins was studied as stimulation of lipid synthesis using primary rat adipocytes. Thymidine incorporation in Saos-2 cells was used to characterize the mitogenic activity. CONCLUSIONS: The binding of insulin glargine and its metabolites M1 and M2 to the IR were similar and correlated well with their corresponding autophosphorylation and metabolic activities in vitro. No differences were found towards the two IR isoforms A or B. Insulin glargine showed a higher affinity for IGF1R than insulin, resulting in a lower EC(50) value for autophosphorylation of the receptor and a more potent stimulation of thymidine incorporation in Saos-2 cells. In contrast, the metabolites M1 and M2 were significantly less active in binding to and activation of the IGF1R and their mitogenicity in Saos-2 cells was equal to human insulin. These findings strongly support the idea that insulin glargine metabolites contribute with the same potency as insulin glargine to blood glucose control but lead to significantly reduced growth-promoting activity. |
format | Text |
id | pubmed-2832019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-28320192010-03-06 In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites Sommerfeld, Mark R. Müller, Günter Tschank, Georg Seipke, Gerhard Habermann, Paul Kurrle, Roland Tennagels, Norbert PLoS One Research Article BACKGROUND: Insulin glargine (Lantus®) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([Gly(A21)]insulin) and M2 ([Gly(A21),des-Thr(B30)]insulin). The aim of this study was to characterize the glargine metabolites in vitro with regard to their insulin receptor (IR) and IGF-1 receptor (IGF1R) binding and signaling properties as well as their metabolic and mitogenic activities. METHODS: The affinity of human insulin, insulin glargine and its metabolites to the IR isoforms A and B or IGF1R was analyzed in a competitive binding assay using SPA technology. Receptor autophosphorylation activities were studied via In-Cell Western in CHO and MEF cells overexpressing human IR-A and IR-B or IGF1R, respectively. The metabolic response of the insulins was studied as stimulation of lipid synthesis using primary rat adipocytes. Thymidine incorporation in Saos-2 cells was used to characterize the mitogenic activity. CONCLUSIONS: The binding of insulin glargine and its metabolites M1 and M2 to the IR were similar and correlated well with their corresponding autophosphorylation and metabolic activities in vitro. No differences were found towards the two IR isoforms A or B. Insulin glargine showed a higher affinity for IGF1R than insulin, resulting in a lower EC(50) value for autophosphorylation of the receptor and a more potent stimulation of thymidine incorporation in Saos-2 cells. In contrast, the metabolites M1 and M2 were significantly less active in binding to and activation of the IGF1R and their mitogenicity in Saos-2 cells was equal to human insulin. These findings strongly support the idea that insulin glargine metabolites contribute with the same potency as insulin glargine to blood glucose control but lead to significantly reduced growth-promoting activity. Public Library of Science 2010-03-04 /pmc/articles/PMC2832019/ /pubmed/20209060 http://dx.doi.org/10.1371/journal.pone.0009540 Text en Sommerfeld et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sommerfeld, Mark R. Müller, Günter Tschank, Georg Seipke, Gerhard Habermann, Paul Kurrle, Roland Tennagels, Norbert In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites |
title |
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites |
title_full |
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites |
title_fullStr |
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites |
title_full_unstemmed |
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites |
title_short |
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites |
title_sort | in vitro metabolic and mitogenic signaling of insulin glargine and its metabolites |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832019/ https://www.ncbi.nlm.nih.gov/pubmed/20209060 http://dx.doi.org/10.1371/journal.pone.0009540 |
work_keys_str_mv | AT sommerfeldmarkr invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites AT mullergunter invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites AT tschankgeorg invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites AT seipkegerhard invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites AT habermannpaul invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites AT kurrleroland invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites AT tennagelsnorbert invitrometabolicandmitogenicsignalingofinsulinglargineanditsmetabolites |